Loading
NASDAQHealthcareMedical - Specialties
Latest quote
$7.24
+$0.26 · +3.72%
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
Previous close
$7.24
+$0.26 · +3.72%
Regular session · ET · Market data may be delayed.
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
Day range
Current $7.24
52-week range
Current $7.24
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
91
Deep Value
Sentiment
50
Mixed
Risk
75
High Risk
Momentum
24
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
Day range
Current $7.24
52-week range
Current $7.24
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 22.36M USD | 27.04M USD | 20.35M USD | 27.66M USD | 20.51M USD |
| Cost of goods sold | 9.69M USD | 13.77M USD | 14.37M USD | 18M USD | 12.44M USD |
| Gross profit | 12.67M USD | 13.27M USD | 5.98M USD | 9.66M USD | 8.07M USD |
| Research and development | 13.79M USD | 24.18M USD | 20.25M USD | 19.65M USD | 17.22M USD |
| Selling, general, and administrative | 35.53M USD | 46.83M USD | 41.8M USD | 46.82M USD | 62.36M USD |
| Operating expenses | 49.32M USD | 71.01M USD | 62.17M USD | 66.47M USD | 84.56M USD |
| Interest income | 943K USD | 1.12M USD | 1.87M USD | 506K USD | 44K USD |
| Interest expense | 3.36M USD | 96K USD | 645K USD | 2.68M USD | 84K USD |
| Depreciation and amortization | 3.56M USD | 7.43M USD | 4.99M USD | 4.72M USD | 4.46M USD |
| Operating income | −36.66M USD | −57.74M USD | −56.19M USD | −56.81M USD | −76.49M USD |
| Net income | −41.71M USD | −42.75M USD | −59.43M USD | −62.19M USD | −76.76M USD |
Company facts updated Sep 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$12.50
72.65% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWC
Dimensional - US Sustainability Core 1 ETFDFSU
U.S. Micro Cap Portfolio ETFDFMCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
